EVIR-expressing DCs efficiently deposited OVA+MC38 tumor-derived EVs on their surface via cross-dressing and enhanced priming of SIINFEKL-specific OT1 CD8 T cells (Squadrito et al., 2018). This evidence concerns the gene CD8A and neoplasm.